Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy

Figure 2 Computed tomography scans (A) prior to and (B) 4 mo after initiating sunitinib treatment, showing a partial response according to the response evaluation criteria in solid tumors criteria of a retroperitoneal lymphadenopathy (arrow), and a decrease in tumor density.